These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24568920)

  • 1. [Therapentic efficacy of recombinant human growth hormone in postpuberal children with idiopathic short stature].
    Luo JM; He YQ; Liu M
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):208-10. PubMed ID: 24568920
    [No Abstract]   [Full Text] [Related]  

  • 2. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency.
    Frindik JP; Kemp SF; Hunold JJ
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():607-12. PubMed ID: 12795361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors determining growth response in recombinant growth hormone treatment of growth hormone deficient children].
    Pan SN; Du ML; Chen HS
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):544-5. PubMed ID: 17044985
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of growth hormone treatment for idiopathic short stature.
    Cuttler L
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5502-4. PubMed ID: 16148349
    [No Abstract]   [Full Text] [Related]  

  • 6. Is final height the only target of paediatric human growth hormone treatment?
    Clayton PE
    Int J Clin Pract Suppl; 2002 May; (126):3-7. PubMed ID: 12090698
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for treating children with idiopathic short stature: laboratory (biochemical).
    Chernausek SD
    Horm Res Paediatr; 2011; 76 Suppl 3():18-20. PubMed ID: 21912152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum levels of IGF-1, ghrelin and nesfatin-1 and clinical significance after treatment with recombinant human growth hormone in children with idiopathic short stature.
    Wang DD; Sun M; Wang X; Cheng YY
    J Biol Regul Homeost Agents; 2019; 33(6):1759-1763. PubMed ID: 31970973
    [No Abstract]   [Full Text] [Related]  

  • 10. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
    Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone therapy in children in Canada: what have we learned in the past decade from an unlimited supply of growth hormone?
    Dean H
    Clin Invest Med; 1999 Apr; 22(2):60-2. PubMed ID: 10340105
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth hormone therapy.
    Dash RJ; Muralidharan R; Talwar V
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy for short stature: is the benefit worth the burden?
    Allen DB
    Pediatrics; 2006 Jul; 118(1):343-8. PubMed ID: 16818584
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic benefits of growth hormone therapy in idiopathic short stature.
    Dahlgren J
    Horm Res Paediatr; 2011; 76 Suppl 3():56-8. PubMed ID: 21912170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term response to GH therapy in short children with a delayed infancy-childhood transition (DICT).
    Albertsson-Wikland K; Kriström B; Jonsson B; Hochberg Z
    Pediatr Res; 2011 Jun; 69(6):504-10. PubMed ID: 21297523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV; Dana K; Frane J; Lippe B
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment of idiopathic short stature: clinical studies.
    Hintz RL
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S6-8. PubMed ID: 16039887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of growth hormone in children.
    Hindmarsh PC; Dattani MT
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):260-8. PubMed ID: 16932297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.